Insufficient Data
Stock has not been able to generate better return on equity than bank FD
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Too much promoter holding pledged
—
—
—
Wockhardt Limited manufactures and markets pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines.
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has decreased by 1.39%
A significant proportion of promoter holdings is pledged
In last 3 months, mutual fund holding of the company has almost stayed constant
3 days ago•Business Today
3 days ago•Economic Times
3 days ago•Business Standard
Wockhardt Limited has informed the Exchange about press release dated 16-Aug-2022 titled Wockhardt announces successful initiation of Global Phase 3 Clinical Study of its novel antibiotic WCK 5222 | Download
Wockhardt Limited has informed the Exchange about press release dated 16-Aug-2022 titled Wockhardt announces successful initiation of Global Phase 3 Clinical Study of its novel antibiotic WCK 5222 | Download
Pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, we hereby confirm that there has been no deviation in the utilisation of Issue proceeds from the objects as stated in the Letter of Offer for Rights Issue dated 4th March 2022. | Download
Pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, we hereby confirm that there has been no deviation in the utilisation of Issue proceeds from the objects as stated in the Letter of Offer for Rights Issue dated 4th March 2022. | Download
Interim • Div/Share: ₹ 10
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data